- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Major Depressive Disorder In Chronic Kidney Disease
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
*Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Jill Green, PhD, and Chip Meyer, PhD are employees of OPDC.
Featured Speakers
Rima Kang, MD
Assistant Professor of Clinical MedicineDivision of Nephrology, The Ohio State University, Columbus, Ohio*
Upon joining faculty at Ohio State, Dr Kang has become the lead nephrologist in cystic kidney disease care and was instrumental in developing a specialty clinic at Ohio State with an emphasis in ADPKD and CKD. Dr Kang continues to advocate for improved patient care and is an active member in multiple associations and committees, including the National Kidney Foundation (NKF), the Internal Medicine Quality and Patient Safety Committee, and the Internal Medicine Diversity and Inclusion Committee. Dr Kang received her medical degree from Northeast Ohio Medical University, and completed her residency in Internal Medicine at the University of Cincinnati Medical Center in Cincinnati, Ohio. Dr Kang then went on to complete a distinguished fellowship in Nephrology at The Ohio State University Wexner Medical Center.
Jill A Green, PhD
Nephrology Medical Science DirectorOtsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Medical Science Director in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, Ohio chapter for over 12 years where she has been active in fundraising and advocacy efforts.
Chip Meyer, PhD
Senior Medical Science Liaison-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Chip Meyer, PhD, is a Senior Medical Science Liaison in the neuroscience division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Meyer received hisPhD in Behavioral Neuroscience and Psychopharmacology from the University of Kentucky where he conducted pre-clinical research and drug development in the area of substance use disorders. He went on to complete a postdoctoral fellowship in Human BehavioralPharmacology at the University of Vermont where he conducted clinical research in substance use disorders.
Location
Online via NephU.org
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
